| BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer M Xing, WH Westra, RP Tufano, Y Cohen, E Rosenbaum, KJ Rhoden, ... The Journal of Clinical Endocrinology & Metabolism 90 (12), 6373-6379, 2005 | 1267 | 2005 |
| Randomized phase II trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-trastuzumab in uterine serous carcinomas that overexpress human epidermal growth factor … AN Fader, DM Roque, E Siegel, N Buza, P Hui, O Abdelghany, ... Journal of Clinical Oncology 36 (20), 2044-2051, 2018 | 439 | 2018 |
| Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma S Zhao, M Choi, JD Overton, S Bellone, DM Roque, E Cocco, F Guzzo, ... Proceedings of the National Academy of Sciences 110 (8), 2916-2921, 2013 | 339 | 2013 |
| Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry P Hui*, JG Howe*, J Crouch, M Nimmakayalu, MB Qumsiyeh, G Tallini, ... Leukemia & lymphoma 44 (8), 1385-1394, 2003 | 291 | 2003 |
| SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity CBF Vogels, AE Watkins, CA Harden, DE Brackney, J Shafer, J Wang, ... Med 2 (3), 263-280. e6, 2021 | 290 | 2021 |
| Randomized phase II trial of carboplatin–paclitaxel compared with carboplatin–paclitaxel–trastuzumab in advanced (stage III–IV) or recurrent uterine serous carcinomas that … AN Fader, DM Roque, E Siegel, N Buza, P Hui, O Abdelghany, ... Clinical Cancer Research 26 (15), 3928-3935, 2020 | 246 | 2020 |
| Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy MG Kelly, DM O'malley, P Hui, J McAlpine, H Yu, TJ Rutherford, M Azodi, ... Gynecologic oncology 98 (3), 353-359, 2005 | 242 | 2005 |
| Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial–mesenchymal transition S Zhao, S Bellone, S Lopez, D Thakral, C Schwab, DP English, J Black, ... Proceedings of the National Academy of Sciences 113 (43), 12238-12243, 2016 | 226 | 2016 |
| Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2 CBF Vogels, MI Breban, IM Ott, T Alpert, ME Petrone, AE Watkins, ... PLoS biology 19 (5), e3001236, 2021 | 224 | 2021 |
| Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis KT Patton, L Cheng, V Papavero, MG Blum, AV Yeldandi, BP Adley, ... Modern pathology 19 (1), 130-140, 2006 | 214 | 2006 |
| Comparative transmissibility of SARS-CoV-2 variants delta and alpha in New England, USA R Earnest, R Uddin, N Matluk, N Renzette, SE Turbett, KJ Siddle, C Loreth, ... Cell Reports Medicine 3 (4), 2022 | 204 | 2022 |
| Minimal uterine serous carcinoma: a clinicopathological study of 40 cases P Hui, M Kelly, DM O'Malley, F Tavassoli, PE Schwartz Modern Pathology 18 (1), 75-82, 2005 | 195 | 2005 |
| Toward standard HER2 testing of endometrial serous carcinoma: 4-year experience at a large academic center and recommendations for clinical practice N Buza, DP English, AD Santin, P Hui Modern Pathology 26 (12), 1605-1612, 2013 | 175 | 2013 |
| A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk E Ratner, L Lu, M Boeke, R Barnett, S Nallur, LJ Chin, C Pelletier, ... Cancer research 70 (16), 6509-6515, 2010 | 169 | 2010 |
| Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal" PEComatosis": A clinicopathological study with comparative genomic … O Fadare, V Parkash, Y Yilmaz, MR Mariappan, L Ma, D Hileeto, ... World journal of surgical oncology 2, 1-12, 2004 | 159 | 2004 |
| A retrospective population-based comparison of HER2 immunohistochemistry and fluorescence in situ hybridization in breast carcinomas: impact of 2007 American Society of … KA Schalper, S Kumar, P Hui, DL Rimm, P Gershkovich Archives of Pathology and Laboratory Medicine 138 (2), 213-219, 2014 | 158 | 2014 |
| Early introductions and transmission of SARS-CoV-2 variant B. 1.1. 7 in the United States T Alpert, AF Brito, E Lasek-Nesselquist, J Rothman, AL Valesano, ... Cell 184 (10), 2595-2604. e13, 2021 | 150 | 2021 |
| Hydatidiform moles: genetic basis and precision diagnosis P Hui, N Buza, KM Murphy, BM Ronnett Annual Review of Pathology: Mechanisms of Disease 12 (1), 449-485, 2017 | 149 | 2017 |
| BRAFV600E mutation in papillary thyroid microcarcinoma: a genotype–phenotype correlation RK Virk, AL Van Dyke, A Finkelstein, A Prasad, J Gibson, P Hui, ... Modern pathology 26 (1), 62-70, 2013 | 133 | 2013 |
| Review of leiomyoma variants EK Arleo, PE Schwartz, P Hui, S McCarthy American journal of roentgenology 205 (4), 912-921, 2015 | 128 | 2015 |